Menu
GeneBe

SEPTIN5

septin 5, the group of Septins

Basic information

Region (hg38): 22:19714502-19724224

Previous symbols: [ "PNUTL1", "SEPT5" ]

Links

ENSG00000184702NCBI:5413OMIM:602724HGNC:9164Uniprot:Q99719AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SEPTIN5 gene.

  • not provided (8 variants)
  • Inborn genetic diseases (6 variants)
  • Abnormal bleeding (1 variants)
  • Macrothrombocytopenia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEPTIN5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
1
clinvar
6
missense
4
clinvar
1
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
2
clinvar
2
Total 0 0 4 8 1

Variants in SEPTIN5

This is a list of pathogenic ClinVar variants found in the SEPTIN5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
22-19714616-A-C not specified Uncertain significance (Aug 02, 2023)2615707
22-19714623-C-T not specified Uncertain significance (May 31, 2022)3160152
22-19714624-G-A Benign (Sep 12, 2018)774360
22-19719838-C-A not specified Uncertain significance (Oct 03, 2022)3160147
22-19719867-G-T not specified Uncertain significance (Aug 02, 2023)2602942
22-19719874-A-C not specified Uncertain significance (Jan 22, 2024)3160148
22-19720124-G-A not specified Likely benign (May 26, 2023)2520103
22-19720141-C-G not specified Uncertain significance (Dec 02, 2021)3160149
22-19720192-A-G not specified Uncertain significance (Dec 27, 2023)3160150
22-19720202-C-T not specified Uncertain significance (Jan 16, 2024)3160151
22-19720346-A-C not specified Uncertain significance (Sep 16, 2021)3160153
22-19720439-C-G not specified Uncertain significance (Jan 03, 2024)3160154
22-19720446-C-G not specified Uncertain significance (Jan 10, 2022)3160155
22-19720550-C-T Likely benign (Jul 16, 2018)760618
22-19720553-C-T not specified Uncertain significance (Mar 28, 2023)2530718
22-19720675-G-A Likely benign (Apr 03, 2018)738672
22-19720772-G-A not specified Uncertain significance (Feb 28, 2024)3160156
22-19720845-C-T Likely benign (May 21, 2018)746930
22-19720858-C-T not specified Uncertain significance (Jan 06, 2023)2454729
22-19721697-C-A Likely benign (May 21, 2018)744189
22-19721850-G-T not specified Likely benign (Jun 07, 2023)2559197
22-19721884-C-T not specified Uncertain significance (Oct 21, 2021)3160157
22-19721911-GTGCACTACGAGAACTACCGCGCGCACTGCATCCAGCAGATGACCAGGTGCGCGCCCCAGCCGCGAGCCAGACCTCGCCCCTCTGGCCCCGCCCACGTCTCCATAACTGAGGGCCGGTCCTGTCAGCCCACCCAGACTTGAACTTTGCACCATTCCCTAAGCCCCCCCCCTCCCCCAGAGCCTGGTCTCCCTAGAACCAAGTCCAGGGCTGTGAGGGCTCCGGAGGGCAGGGCCTCAGCAGTGGCGGGGATGGGCCAGGCATCGCCAGCCCACGCTGAGCCTCCCGGTGGCGCCGCCCCGCCCATCCTCCCCCCCGCCCCGCGCAGCAAACTGACCCAGGACAGCCGCATGGAGAGCCCCATCCCGATCCTGCCGCTGCCCACCCCGGACGCCGAGACTGAGAAGCTTATCAGGATGAAGGATGAGGAAGTATGTGGGGCGGCGGGGGCGGCGGAGGCGGGCGTCAGGGATGCTCCTCCGCGGTGCTGCTCACCCGCCGGGTTGTCTCCGCCCGCAGCTGAGGCGCATGCAGGAGATGCTGCAGAGGATGAAGCAGCAGATGCAGGACCAGTGACGCTCGCCGCGGACACACCGTCCGTCTCCGGGACGCCCTCGCACCCCTGGACACCAGACCGGACTGTTCCCGACCCGGAGACGCGGGGCCACAGCCCCCAGCTGACCCTAATTTATTCTCAGCACCACCCCCTCCCAGGTCATTGTGTCTGTTTCCGAGGGGCCTGGACCGTAGCCCCCGCCCAGCTGGCCCTCTCTGACCTTGGGGGATCAGGAGCGAAGTTGGGCGGGACTTCAGAGATCCGCCTCCCTTGCCCTTCCCCCGCCCCCGGACGGTCACAGCACCCAAACCGCAGGCCCTGCTCTGGCAGGCAGGCAAAGCTAGGCAGAAGAGGATTCCCAGGATCCTGGGTCTGTTCCCTGCCCCAGTGCTGCAGAACGGACTTGGGAGCCCTCCTTTGCCTGCTCCCGCGGGTCACCCAGCGAGTGCTGAGACCCCATTTTCTGTCGAGGCGGGCCGAGTCTTCCCTTATCCCCAGACGCCTAGCGGGCAGGGTTGGGCTGAATCAAATGGGAGCCCTCCAGACATAAGGAGGCCAGAGGCTGCAAGGAGCGGGGTCGTGACCGCTTACACCCCTTCTCCACAGCCCGGCCCGACCTGGAGGGCCCCCGGGGCACTGGGCGGTGAGCCACCTCCTGGCAACTCTCGGTGCCGTCCCCTGCCCTCGCTCGAGGCCTCTTCTCCCCAGCACCGCTGTGGTGTGCCGGGATCCTGAGCCTAGGCCTCCCGATGTTCCCACCCGCATGATCCCTTCCCGCCACACGATGCTCCGTTTTCTTCCGTTGTGAATGCCGCGTCCTGTCCTGGTGACAGGAGAACAATGTTGGTGAACGTCGCAGCGGGTGTCCGAGTGCTCCGTGTGCCCCTGAGAGCGGGTGGGAGCGGAAGCCTGAGCGGCCTGCGGCCTCCGGCGATAGTGTGCTATCTGCCGCTGCAGCGCGCGTCCGCGCGGCCTCTGGGCTATTTCTGGCCAGGCCGCAGCACTGTGGTCGGTGCGGGCGTGGCAGGGGCGGGGCGGCCTTATCGCTCGGCTCTCCCGCCTACGCCTCCCGCTGCAGAGTAAGCCGGGCTGCCGTCTTCTCGCCATGGGCTCCGGTGAGTCTGGAGTCCGGTCGGGCCCCCGGCTGCTCCCTAGGCCGACCCGGGTTGAGAGGAGCTCTGGTCGTTTGGCTGCAGCTGGGAGAGACTTGGGTCAGACTTAGAGGGGACTTCCAGCCGGCGTGCGGGGTGGTCAGGGTGGAGAGGCTGGCGGGCTACCGGGACGCCGGGCATCAGGGGCTGGATGGAGCCGGGCCGGCAGTCTGGGTACTCAGAGATGTCGCCCAGGTGCCCGCCGACCGCTCGGCTTACTGCGGCGCTTCCCTTGCAGGGCCGCGCGGGGCGCTGAGCTTACTGCTCCTGCTGCTGGCCCCGCCGAGCCGCCCGGCCGCAGGTTGCCCGGCGCCCTGTAGCTGCGCGGGGACGCTCGTGGACTGCGGGCGCCGCGGGCTGACTTGGGCCTCGCTGCCGACCGCCTTCCCTGTCGACACAACCGAGCTGGTGCTGACCGGCAACAACCTGACGGCGCTGCCGCCGGGGCTGCTGGACGCGCTGCCCGCGCTGCGCACCGCACACCTGGGCGCCAACCCCTGGCGCTGCGACTGCCGCCTTGTGCCGCTGCGCGCCTGGCTGGCCGGCCGCCCCGAGCGTGCGCCCTACCGCGACCTGCGTTGCGTGGCGCCCCCAGCGCTGCGCGGCCGCCTGCTGCCCTATCTGGCCGAGGACGAGCTGCGCGCCGCTTGCGCTCCCGGCCCGCTCTGCTGGGGGGCGCTGGCGGCGCAGCTTGCGCTGCTGGGCCTTGGGCTGCTGCACGCGTTGCTGCTGGTGCTGCTGCTGTGCCGCCTGCGGAGGCTGCGGGCCCGGGCCCGCGCTCGCGCCGCAGCCCGGCTGTCGCTGACCGACCCGCTGGTGGCCGAGCGAGCCGGAACCGACGAGTCCTGAGGAGAGAACCGGTGCGTCCTGAGGAGAGAACCGGCGCTGGGCAACACGGGCCTGCAAACTCGACAGGACCCTGCCCGAGGGGCCCTCGCGCCAACCTGGACCGGTCCCCGCCTCCTCCGCTGCCCAATCTCTCAGACCCACCCCACCTGCAGGCCCAGACCACGTGGGACAGAACTCCTGCCCACCCTACCCCGAGGGAGGCGAACCCGCACTTCCAGGCTTGGGAGGACCATGGGGCACAATGCGGTCCAGACCCTGCTGCGTCTCCCTTCCAAACTCTGGTGCTGAATAAACCCTTCTGATCTGGTCTTCTCTGCACGACTGAC-G Macrothrombocytopenia • Abnormal bleeding Conflicting classifications of pathogenicity (Feb 01, 2019)627512
22-19721937-C-G not specified Uncertain significance (Sep 27, 2021)3160158
22-19721966-C-A Likely benign (Oct 10, 2018)792291

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SEPTIN5protein_codingprotein_codingENST00000455784 1210309
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9270.0733125521071255280.0000279
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.631282430.5260.00001572459
Missense in Polyphen58120.160.482681137
Synonymous-0.7491111011.090.00000727664
Loss of Function3.70321.60.1390.00000106245

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002900.0000290
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00002660.0000264
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). May play a role in platelet secretion (By similarity). {ECO:0000250, ECO:0000305}.;
Pathway
Parkinson,s disease - Homo sapiens (human);Parkin-Ubiquitin Proteasomal System pathway;Parkinsons Disease Pathway (Consensus)

Recessive Scores

pRec
0.278

Intolerance Scores

loftool
0.413
rvis_EVS
-0.34
rvis_percentile_EVS
30.07

Haploinsufficiency Scores

pHI
0.284
hipred
Y
hipred_score
0.882
ghis
0.630

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sept5
Phenotype
homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype;

Gene ontology

Biological process
synaptic vesicle targeting;regulation of exocytosis;cytoskeleton-dependent cytokinesis;regulation of synaptic vesicle exocytosis
Cellular component
plasma membrane;septin ring;synaptic vesicle;microtubule cytoskeleton;septin complex
Molecular function
GTPase activity;structural molecule activity;protein binding;GTP binding;protein-containing complex scaffold activity